Morning Minute: Paradigm Raises $1.2B Fund as Crypto AI Push
Paradigm just closed a $1.2B fund, signaling a bold move at the intersection of crypto and AI. This Morning Minute ex...
Which Index Funds Are Tax Efficient 2024
This quick guide shows Which Index Funds Are Tax Efficient 2024 and the key factors to compare for better after-tax outcomes.
24,458 articles
Canary Grayscale Launch ETFs with Staking Rewards in US
Two US-listed SUI ETFs debut with staking rewards, signaling a new era for crypto exposure in regulated markets. SUI ...
GDX vs GDXJ: Who Wins the Gold Boom - Senior or Junior
Gold miners ETFs are in focus as 2026's rally tests the resilience of senior producers versus junior explorers. This ...
TransAlta Stock Fund Trims: What It Signals for Investors
A major fund reduced its TransAlta stake in Q4, sparking questions about the stock’s trajectory. This article explain...
Should Lock Rate Now? CD Decisions Amid Fed Rate Watch
CD rates have paused as investors await the Federal Reserve’s next move. This report explains when to lock in a CD ra...
Vast Takes a Giant Leap Toward Private Space Station
A new private space station race is heating up, and Vast is stepping in with a bold plan. This could shift how invest...
Fake Agents Told Call: How to Protect Your Money From Scams
An escalating scam shows how fake agents manipulate emotions to steal savings. Learn the warning signs, real-world st...
Midstream Dividend ETFs Yielding High, Beating Markets
A trio of midstream dividend ETFs yielding more than 5% are delivering market-beating performance, offering both inco...
Micron’s Right Could Lift Memory ETFs Through 2027
Micron’s latest earnings hints at a longer memory cycle, potentially lifting these memory ETFs through 2027. Here’s h...
CertifID Expands Platform with AI-Powered Closing Tools
CertifID unveils a broader, end-to-end closing platform, adding AI payoff ordering, document workflows, and digital p...
Investors Face Bitcoin Mining Losses After $22M Scheme
U.S. regulators say a crypto venture raised about $22 million from more than 380 investors, yet only a sliver went to...
Crispr Therapeutics Editas Medicine: Better Buy in 2026?
Two top gene-editing names, two very different strategies. This guide breaks down CRISPR Therapeutics and Editas Medi...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status